Nasu-Hakola disease is a rare autosomal recessive disorder associated to mutations in TREM2 and DAP12 genes, neuropathologically characterized by leukoencephalopathy with axonal spheroids. We report the neuropathologic findings of a 51-year-old female with a homozygous mutation (Q33X) of TREM2 gene. Beside severe cerebral atrophy and hallmarks of Nasu-Hakola disease, significant Alzheimer’s disease lesions were present. Neurofibrillary changes showed an atypical topographic distribution being severe at spots in the neocortex while sparing the mesial temporal structures. Our finding suggests that TREM2 genetic defects may favor Alzheimer’s disease pathology with neurofibrillary changes not following the hierarchical staging of cortical involvement identified by Braak.
MatsushitaM (1982) Nasu-Hakola’s disease: An example of geographic neuropathology?Neurology32, 329.
2.
HakolaHP (1972) Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl232, 1–173.
3.
NorioR, NevanlinnaHR, PerheentupaJ (1973) Hereditary diseases in Finland; rare flora in rare soul. Ann Clin Res5, 109–141.
4.
De la ChapelleA (1993) Disease gene mapping in isolated human populations: The example of Finland. J Med Genet30, 857–865.
5.
KanekoM, SanoK, NakayamaJ, AmanoN (2010) Nasu-Hakola disease: The first case reported by Nasu and review. Neuropathology30, 463–470.
6.
MontalbettiL, SoragnaD, RattiMT, BiniP, BusconeS, MogliaetA (2004) Nasu-Hakola disease: A rare entity in Italy. Critical review of the literature. Funct Neurol19, 171–179.
7.
ErrichielloE, DardiotisE, ManninoF, PalonevaJ, MattinaT, ZuffardiO (2019) Phenotypic expansion in Nasu-Hakola disease: Immunological findings in three patients and proposal of a unifying pathogenic hypothesis. Front Immunol10, 1685.
8.
PalonevaJ, ManninenT, ChristmanG, HovanesK, MandelinJ, AdolfssonR, BianchinM, BirdT, MirandaR, SalmaggiA, TranebjaergL, KonttinenY, PeltonenetL (2002) Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet71, 656–662.
9.
PekkarinenP, HovattaI, HakolaP, JärviO, KestiläM, LenkkeriU, AdolfssonR, HolmgrenG, NylanderPO, TranebjaergL, TerwilligerJD, LönnqvistJ, PeltonenL (1998) Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13. Am J Hum Genet62, 362–372.
10.
GhezziL, CarandiniT, ArighiA, FenoglioC, ArcaroM, De RizM, PietroboniAM, FumagalliGG, BasilicoP, CalviA, ScarioniM, ColombiA, SerpenteM, MarottaG, BentiR, ScarpiniE, GalimbertiD (2017) Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation. Neurology89, 12.
11.
CarmonaS, ZahsK, WuE, DakinK, BrasJ, GuerreiroR (2018) The role of TREM2 in Alzheimer’s disease and other neurodegenerative disorders. Lancet Neurol17, 721–730.
12.
KöseoğluE, TepgeçF, YetkinMF, UygunerO, EkinciA, AbdülrezzakU, HanağasiH (2018) Nasu Hakola disease: A rare cause of dementia and cystic bone lesions, report of a New Turkish family. Noro Psikiyatr Ars55, 98–102.
13.
LacourM, QuenezO, Rovelet-LecruxA, SalomonB, RousseauS, RichardAC, Quillard-MuraineM, PasquierF, Rollin-SillaireA, MartinaudO, ZareaA, de la SayetteV, Boutoleau-BretonniereC, Etcharry-BouyxF, ChauviréV, SarazinM, le BerI, EpelbaumS, JonveauxT, RouaudO, CeccaldiM, GodefroyO, FormaglioM, CroisileB, AuriacombeS, MagninE, SauvéeM, MarelliC, GabelleA, ParienteJ, PaquetC, BolandA, DeleuzeJF, CampionD, HannequinD, NicolasG, WallonD; collaborators of the CNR-MAJ (2019) Causative mutations and genetic risk factors in sporadic early onset Alzheimer’s disease before 51 years. J Alzheimers Dis71, 227–243.
14.
SoragnaD, PapiL, RattiMT, SestiniR, TuplerR, MontalbettiL (2003) An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene. J Neurol Neurosurg Psychiatry74, 825–826.
15.
ThalDR, RübU, OrantesM, BraakH (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology58, 1791–1800.
16.
KatsumotoA, TakeuchiH, TanakaF (2019) Tau pathology in chronic traumatic encephalopathy and Alzheimer’s disease: Similarities and differences. Front Neurol10, 980.
17.
BraakH, AlafuzoffI, ArzbergerT, KretzschmarH, Del TrediciK (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol112, 389–404.
